Hypercalcemia in critically ill patients taking 10,000 IU of vitamin D (many solutions) – Oct 2019

Hypercalcemia Without Hypervitaminosis D During Cholecalciferol Supplementation in Critically Ill Patients.

Nutr Clin Pract. 2019 Oct 11. doi: 10.1002/ncp.10407.

VitaminDWiki

Most groups taking high-dose vitamin D do one or more of the following:

  1. Increase Magnesium
  2. Increase Vitamin K
  3. Reduce Calcium intake - especially pills
  4. Increase Water

The founder of VitaminDWiki takes 20,000 IU Vitamin D average along with Magnesium and Vitamin K


17 Items in both categories Calcium and Vitamin K:


27 Items in both categories Calcium and Magnesium:



Holmes WL1, Maish GO 3rd2, Minard G2, Croce MA2, Dickerson RN3.
1 Department of Pharmacy, Regional One Health, Memphis, Tennessee, USA.
2 Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
3 Dept of Clinical Pharmacy and Translational Science, U. of Tennessee Health Science Center, Memphis, TN, USA.

BACKGROUND:
Vitamin D deficiency during critical illness has been associated with worsened outcomes. Because most critically ill patients with severe traumatic injuries are vitamin D deficient, we investigated the efficacy and safety of cholecalciferol therapy for these patients.

METHODS:
Fifty-three patients (>17 years of age) admitted to the trauma intensive care unit who had a serum 25-hydroxy vitamin D (25-OH vit D) concentration <20 ng/mL were given 10,000 IU of cholecalciferol daily. Efficacy was defined as achievement of a 25-OH vit D of 30-79.9 ng/mL. Safety was evaluated by the presence of hypercalcemia (serum ionized calcium [iCa] >1.32 mmol/L) or hypervitaminosis D (25-OH vit D >79.9 nmol/L). Patients were monitored for 2 weeks during cholecalciferol therapy.

RESULTS:
Twenty-four patients (45%) achieved target 25-OH vit D. No patients experienced hypervitaminosis D. Hypercalcemia occurred in 40% (n = 21) of patients; 2 patients experienced an iCa >1.49 nmol/L. 25-OH vit D was significantly greater for those who developed hypercalcemia (37.2 + 11.2 vs 28.4 + 5.6 ng/mL, respectively, P < 0.001) by the second week of cholecalciferol. Of 24 patients who achieved target 25-OH vit D, 14 (58%) experienced hypercalcemia in contrast to 24% of patients (7 out of 29) who did not achieve target 25-OH vit D (P = 0.024).

CONCLUSIONS:
Cholecalciferol normalized serum 25-OH vit D concentrations in less than half of patients yet was associated with a substantial proportion of patients with hypercalcemia without hypervitaminosis D.


There have been 4676 visits to this page

47 visitors, last modified 22 Jun, 2024,
Printer Friendly Follow this page for updates